Table of Contents
Fluoxetine, commonly known by its brand name Prozac, is a widely prescribed selective serotonin reuptake inhibitor (SSRI) used primarily to treat depression, anxiety disorders, and certain other mental health conditions. Understanding its pharmacokinetics — how the drug is absorbed, distributed, and metabolized in the body — is essential for optimizing its therapeutic efficacy and minimizing side effects.
Absorption of Fluoxetine
After oral administration, fluoxetine is rapidly absorbed from the gastrointestinal tract. Its bioavailability is approximately 72%, which means a significant portion of the dose reaches systemic circulation. The drug’s absorption is not significantly affected by food, allowing flexible dosing schedules. Peak plasma concentrations are typically reached within 6 to 8 hours after ingestion.
Distribution of Fluoxetine
Once absorbed, fluoxetine extensively binds to plasma proteins, mainly albumin, with about 94.5% bound. This high degree of protein binding influences its distribution and free (active) drug concentration. Fluoxetine crosses the blood-brain barrier readily, which is essential for its antidepressant effects. Its volume of distribution is approximately 21 liters per kilogram, indicating wide distribution throughout body tissues.
Metabolism of Fluoxetine
Fluoxetine undergoes extensive hepatic metabolism primarily via the cytochrome P450 enzyme system, especially CYP2D6 and CYP2C19. It is metabolized into norfluoxetine, an active metabolite that contributes to the drug’s therapeutic effects. Both fluoxetine and norfluoxetine have long half-lives, approximately 4 to 6 days for fluoxetine and 7 to 15 days for norfluoxetine, leading to a gradual accumulation with repeated dosing.
Implications for Dosing and Therapeutic Monitoring
The long half-life of fluoxetine allows for once-daily dosing and provides a forgiving pharmacokinetic profile, reducing the risk of withdrawal symptoms if doses are missed. However, its extensive metabolism and long half-life mean that it takes several weeks to reach steady-state concentrations. Clinicians should monitor patients for therapeutic response and potential side effects, adjusting doses accordingly.
Conclusion
The pharmacokinetics of fluoxetine — from absorption to metabolism — play a crucial role in its clinical use. Its high bioavailability, extensive tissue distribution, and complex metabolism contribute to its effectiveness as an antidepressant. Understanding these processes helps healthcare providers optimize treatment plans and improve patient outcomes.